Affinity Investment Advisors, LLC Bluebird Bio, Inc. Transaction History

Affinity Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$88.86 - $117.49 $229,525 - $303,476	-2,583 Closed	0 $0
Q1 2018 May 08, 2018	SELL	$105.8 - $150.94 $18,303 - $26,112	-173 Reduced 6.28%	2,583 $441,000
Q4 2017 Feb 07, 2018	SELL	$81.25 - $130.7 $18,281 - $29,407	-225 Reduced 7.55%	2,756 $491,000
Q3 2017 Oct 31, 2017	BUY	$57.74 - $91.42 $172,122 - $272,523	2,981	2,981 $409,000

150

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $643M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Affinity Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Investment Advisors, LLC with notifications on news.